Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Fausto, Avanzini"'
Autor:
Stefano Genovese, Antonio Nicolucci, Mauro Tettamanti, Fabio Robusto, Vito Lepore, Francesco Giorgino, Pierluca Colacioppo, Ida Fortino, Maria Carla Roncaglioni, Antonio D'Ettorre, Fausto Avanzini, Marta Baviera
Publikováno v:
Diabetes, Obesity and Metabolism. 23:1484-1495
Aim To examine the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with other antihyperglycaemic agents (AHAs) in large and unselected populations of the Lomba
Autor:
Maria Carla Roncaglioni, Tommaso Vannini, V Vilei, M Grioni, Emma Riva, D. Saltafossi, Raffaella Amodeo, E L Colombo, G Marelli, C. Moro, E. Di Rocco, L. Chiappa, Fausto Avanzini, P Vandoni
Publikováno v:
Diabetic Medicine. 37:1125-1133
AIM Insulin is the preferred treatment for the control of diabetes in hospital, but it raises the risk of hypoglycaemia, often because oral intake of carbohydrates in hospitalized persons is lower than planned. Our aim was to assess the effect on the
Autor:
Giuseppe Marelli, Fausto Avanzini, Giuseppe Iacuitti, Enrico Planca, Ilaria Frigerio, Giovanna Busi, Liliana Carlino, Laura Cortesi, Maria Carla Roncaglioni, Emma Riva
Publikováno v:
Journal of Diabetes Research, Vol 2015 (2015)
Background. Hypoglycemia due to inadequate carbohydrate intake is a frequent complication of insulin treatment of diabetic in-patients. Objective. To assess the effectiveness of a nurse-managed protocol to prevent hypoglycemia during subcutaneous ins
Externí odkaz:
https://doaj.org/article/6f3c969ca30e4691b1711a3f84916eca
Autor:
Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk, Prevention Study
Publikováno v:
Vascular Health and Risk Management, Vol Volume 2, Pp 507-514 (2006)
Daria Roccatagliata1, Fausto Avanzini1, Lara Monesi1, Vittorio Caimi2, Davide Lauri1, Paolo Longoni3, Roberto Marchioli4, Massimo Tombesi2, Gianni Tognoni1, Maria Carla Roncaglioni1, on behalf of the Collaborative Group Risk and Prevention Study*1Ist
Externí odkaz:
https://doaj.org/article/28e51bb954b04903b338d509b306cc38
Autor:
Fausto Avanzini, Giuseppe Limonta, Stefano Signorini, Donata Saltafossi, Marina Pitto, Jari Intra, Fabrizio Cappellini, Rosanna Falbo, Chiara Fania, Paolo Brambilla
Publikováno v:
Clinica Chimica Acta. 495:1-7
Introduction Chest pain and its clinical manifestations are the most common reasons for presentation to the emergency department (ED). Given that the prevalence of chest pain due to acute myocardial infarction (AMI) in the ED is modest, clinicians sh
Autor:
Antonio D'Ettorre, Ida Fortino, Francesco Giorgino, Antonio Nicolucci, Maria Carla Roncaglioni, Mauro Tettamanti, Vito Lepore, Marta Baviera, Stefano Genovese, Fausto Avanzini, Pierluca Colacioppo, Fabio Robusto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4085671874ec361991008d9308a8a59d
https://doi.org/10.1111/dom.14361/v4/response1
https://doi.org/10.1111/dom.14361/v4/response1
Autor:
Antonio Nicolucci, Stefano Genovese, Mauro Tettamanti, Fausto Avanzini, Marta Baviera, Francesco Giorgino, Fabio Robusto, Pierluca Colacioppo, Antonio D'Ettorre, Vito Lepore, Ida Fortino, Maria Carla Roncaglioni
Background:GLP-1 receptor agonists (G LP-1 RA) and SGLT-2 inhibitors (SGLT-2i) are recommended in type 2 diabetes subjects with established cardiovascular (CV) disease or at high CV risk. The efficacy and safety of GLP-1 RA and SGLT-2i compared with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56a671ef567170a2871ba2f35efda244
https://doi.org/10.21203/rs.3.rs-89359/v1
https://doi.org/10.21203/rs.3.rs-89359/v1
Autor:
Luca Merlino, Mauro Tettamanti, Ida Fortino, Fausto Avanzini, Marta Baviera, Maria Carla Roncaglioni, Tommaso Vannini, Angela Bortolotti, Vittorio Bertele
Publikováno v:
European Journal of Preventive Cardiology. 25:1735-1743
Background The aim of our study was to evaluate whether treatments for peripheral artery disease changed in two different cohorts identified in 2002 and 2008, and whether this had an impact on mortality and major clinical outcomes after six years of
Autor:
Juan Moreira, Monica Marquez Figueroa, Mariella Anselmi, Rosanna Prandi, Cintia Caicedo Montaño, Damon Bell, Oscar Betancour, Fabio Robusto, Tommaso Vannini, Fausto Avanzini, Gianni Tognoni, Maria Carla Roncaglioni, COHEMI Project Study Group
Publikováno v:
Global Heart; Vol 14, No 4 (2019); 373-378
Background: In contrast with the abundance of global epidemiological descriptive data on cardiovascular diseases and their risk factors, information on the outcomes of real populations prospectively followed up in their life and care settings is much
Autor:
Fausto, Avanzini, Giuseppe, Marelli, Donata, Saltafossi, Chiara, Longhi, Stefania, Carbone, Liliana, Carlino, Enrico, Planca, Veronica, Vilei, Maria Carla, Roncaglioni, Emma, Riva, C, Galimberti
Publikováno v:
European Heart Journal: Acute Cardiovascular Care. 5:117-124
To assess the effectiveness, safety and feasibility of the revised, simplified nurse-managed version of our insulin infusion protocol, adapted to the new recommended glycaemic target of 140 to 180 mg/dL (Desio Diabetes Diagram i.v. 140-180).All clini